EMD Serono

EMD Serono is the healthcare business of Merck KGaA, Darmstadt, Germany, in the United States and Canada, and its U.S. healthcare headquarters sits in Boston’s Seaport. The company works to translate the discovery of molecules into meaningful outcomes for people with serious unmet medical needs, focusing on neurology and immunology, oncology and fertility. The Seaport site is a corporate office rather than a public-facing location, and it joins the neighborhood’s growing cluster of life sciences companies.

The company moved its U.S. healthcare headquarters to the Seaport from Rockland, Massachusetts, taking two floors and roughly 60,500 square feet. Its parent company is a science and technology group active in healthcare, life science and electronics, with more than 62,000 employees in 65 countries. In the United States and Canada, the group’s subsidiaries operate under the EMD umbrella name to distinguish them from the separate U.S. company Merck and Co.

What to Know

• EMD Serono’s global research and development hub is in Billerica, Massachusetts.
• The parent company’s healthcare work also covers rare tumors and cardiovascular, metabolic and endocrine conditions.
• Merck KGaA is headquartered in Darmstadt, Germany.
• The parent company runs research grants and innovation challenges for outside scientists.